Durlach J. Chronic fatigue syndrome and chronic primary magnesium deficiency (CFS and CPMD).
Magnes Res. 1992;5:68.
Howard JM, Davies S, Hunnisett A. Magnesium and chronic fatigue syndrome [letter].
Lancet. 1992;340:426.
Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome.
Lancet. 1991;337:757-760.
Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial.
Lancet. 1999;353:455-458.
Jeffcoate WJ. Chronic fatigue syndrome and functional hypoadrenia—fighting vainly the old ennui [letter].
Lancet. 1999;353:424-425.
Dessein PH, Shipton EA. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1618.
Baschetti R
.
Hydrocortisone and chronic fatigue syndrome [letter]
Lancet.
1999;353:1618.
Rea T, Buchwald D. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1618-1619.
Shepherd C. Hydrocortisone and chronic fatigue syndrome [letter].
Lancet. 1999;353:1619-1620.
Deale A, Chalder T, Wessely S. Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Br J Psychiatry. 1998;172:491-492.
Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
Br J Psychiatry. 1998;172:485-490.
Lynch S, Fraser J. Fluoxetine and graded exercise in chronic fatigue syndrome [letter].
Br J Psychiatry. 1998;173:353.
Everitt BS. Analysis of drop-out data in treatment trials [letter].
Br J Psychiatry. 1998;173:271.
Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
Arch Intern Med. 1998;158:908-914.
Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome.
Acta Neurol Scand. 1990;82:209-216.
Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA.
Acta Neurol Scand. 1999;99:112-116.
Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.
Ann Allergy. 1999;82:185-191.
Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome.
Neuropsychobiology. 1997;35:16-23.
Plioplys AV, Plioplys S. Amantadine and L-carnitine treatment of chronic fatigue syndrome.
Neuropsychobiology. 1997;35:16-23.
See DM, Broumand N, Sahl L, et al. In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency patients.
Immunopharmacology. 1997;35:229-235.
Himmel PB, Seligman TM. A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome.
J Clin Rheumatol. 1999;5:56-59.
Cunha BA. Beta-carotene stimulation of natural killer cell activity in adult patients with chronic fatigue syndrome.
CFIDS Chronicle Physicians' Forum. 1993:18-19.
Heath M, Klein NC, Cunha BA. Dose dependent effects of beta carotene therapy in chronic fatigue syndrome [abstract].
Clin Res. 1994;42:345A.
Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome.
Arch Intern Med. 1998;158:908-914.
Martin RWY, Ogston SA, Evans JR. Effects of vitamin and mineral supplementation on symptoms associated with chronic fatigue syndrome with Coxsackie B antibodies.
J Nutr Med. 1994;4:11-23.
Brouwers FM, Van Der Werf S, Bleijenberg G, et al. The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: a double-blind randomized controlled trial.
QJM.
2002;95:677-683.
Kuratsune, H. Effect of Kampo Medicine, “Hochu-ekki-to,” on chronic fatigue syndrome.
Clinic and Research. 1997;74:1837-1845.
Hartz AJ, Bentler S, Noyes R, et al. Randomized controlled trial of Siberian ginseng for chronic fatigue.
Psychol Med. 2004;34:51-61.
Williams G, Waterhouse J, Mugarza J, et al. Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.
Eur J Clin Invest. 2002;32:831-837.
Smith S, Sullivan K. Examining the influence of biological and psychological factors on cognitive performance in chronic fatigue syndrome: a randomized, double-blind, placebo-controlled, crossover study.
Int J Behav Med. 2003;10:162-173.
McDermott C, Richards SC, Thomas PW, et al. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome.
QJM.
2006 Jun 29 [Epub ahead of print].
Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome.
Cochrane Database Syst Rev.
2004;(3):CD003200.
Health Benefits of Chocolate Revealed. Hull and East Yorkshire Hospitals NHS Trust website. Available at:
http://www.hey.nhs.uk/pdf/media/chocolate.pdf. Accessed December 21, 2006.
Yiu YM, Ng SM, Tsui YL, et al. A clinical trial of acupuncture for treating chronic fatigue syndrome in Hong Kong.]
Zhong Xi Yi Jie He Xue Bao.
2007;5:630-633.
White P, Goldsmith K, Johnson A, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial.
Lancet.
2011 Feb 17. [Epub ahead of print]
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.